NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
Go back to NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease| (NASDAQ: NRSN) | Delayed: 0.38 +0.03 (8.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.35 | 52 Week High | $ | |||
| Open | $0.36 | 52 Week Low | $ | |||
| Day High | $0.39 | P/E | N/A | |||
| Day Low | $0.35 | EPS | $ | |||
| Volume | 128,458 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.04 -0.01 (20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 3,721 | |||||
